[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

GB0211295D0 - Treatment of pain - Google Patents

Treatment of pain

Info

Publication number
GB0211295D0
GB0211295D0 GBGB0211295.1A GB0211295A GB0211295D0 GB 0211295 D0 GB0211295 D0 GB 0211295D0 GB 0211295 A GB0211295 A GB 0211295A GB 0211295 D0 GB0211295 D0 GB 0211295D0
Authority
GB
United Kingdom
Prior art keywords
pain
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0211295.1A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University College London
Original Assignee
University College London
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University College London filed Critical University College London
Priority to GBGB0211295.1A priority Critical patent/GB0211295D0/en
Publication of GB0211295D0 publication Critical patent/GB0211295D0/en
Priority to AU2003227944A priority patent/AU2003227944A1/en
Priority to PCT/GB2003/002122 priority patent/WO2003097085A1/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
    • A61K49/0008—Screening agents using (non-human) animal models or transgenic animal models or chimeric hosts, e.g. Alzheimer disease animal model, transgenic model for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Neurology (AREA)
  • Toxicology (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Pathology (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Zoology (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Neurosurgery (AREA)
  • Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
GBGB0211295.1A 2002-05-16 2002-05-16 Treatment of pain Ceased GB0211295D0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
GBGB0211295.1A GB0211295D0 (en) 2002-05-16 2002-05-16 Treatment of pain
AU2003227944A AU2003227944A1 (en) 2002-05-16 2003-05-15 Ddah modulators in the treatment of pain
PCT/GB2003/002122 WO2003097085A1 (en) 2002-05-16 2003-05-15 Ddah modulators in the treatment of pain

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0211295.1A GB0211295D0 (en) 2002-05-16 2002-05-16 Treatment of pain

Publications (1)

Publication Number Publication Date
GB0211295D0 true GB0211295D0 (en) 2002-06-26

Family

ID=9936848

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0211295.1A Ceased GB0211295D0 (en) 2002-05-16 2002-05-16 Treatment of pain

Country Status (3)

Country Link
AU (1) AU2003227944A1 (en)
GB (1) GB0211295D0 (en)
WO (1) WO2003097085A1 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9096663B2 (en) 2001-02-15 2015-08-04 The Board Of Trustees Of The University Of Illinois Compositions and methods for treating conditions related to ephrin signaling with cupredoxins and mutants thereof
US7556810B2 (en) 2005-07-19 2009-07-07 The Board Of Trustees Of The University Of Ilinois Compositions and methods to control angiogenesis with cupredoxins
US7381701B2 (en) 2001-02-15 2008-06-03 The Borad Of Trustees Of The University Of Illinois Compositions and methods for treating conditions related to ephrin signaling with cupredoxins
US9598470B2 (en) 2004-10-07 2017-03-21 Craig W. Beattie Compositions and methods to prevent cancer by stabilizing P53 through non MDM2-mediated pathways
US9968685B2 (en) 2004-10-07 2018-05-15 Brad N. Taylor Methods to treat cancer with cupredoxins
US10675326B2 (en) 2004-10-07 2020-06-09 The Board Of Trustees Of The University Of Illinois Compositions comprising cupredoxins for treating cancer
US9434770B2 (en) 2004-10-07 2016-09-06 Tapas K Das Gupta Modified cupredoxin derived peptides
BRPI0515850A (en) 2004-10-07 2008-08-12 Ananda Chakrabarty transport agents derived from cupredoxin and methods of using them
CA2587444C (en) 2004-11-12 2013-09-10 Ucl Business Plc Guanidine derivatives as inhibitors of ddah
KR20080042804A (en) 2005-07-19 2008-05-15 더 보드 오브 트러스티즈 오브 더 유니버시티 오브 일리노이 Transport agents for crossing the blood-brain barrier and into brain cancer cells, and methods of use thereof
KR20090114414A (en) 2007-02-08 2009-11-03 더 보드 오브 트러스티즈 오브 더 유니버시티 오브 일리노이 Compositions and Methods to prevent cancer with Cupredoxins
EP2398486A4 (en) * 2009-02-20 2012-11-21 Cdg Therapeutics Inc Compositions and methods to prevent and/or treat cancer with pa -card

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60043533D1 (en) * 1999-01-26 2010-01-28 Univ London
US20030138803A1 (en) * 2001-07-27 2003-07-24 Brooksbank Robert Alan Identification and use of molecules implicated in pain

Also Published As

Publication number Publication date
WO2003097085A1 (en) 2003-11-27
AU2003227944A1 (en) 2003-12-02

Similar Documents

Publication Publication Date Title
GB0201850D0 (en) Therapeutic treatment
GB0216321D0 (en) Therapeutic treatment
IL218909A0 (en) Treatment of diabetes
IL164266A0 (en) Treatment of gastroparesis
AU2003300791A1 (en) Combination therapy for the treatment of pain
GB0201674D0 (en) Medical treatment
GB0223367D0 (en) Therapeutic treatment
GB0218879D0 (en) Medical treatment
GB0213869D0 (en) The treatment of pain
GB0211295D0 (en) Treatment of pain
GB0223854D0 (en) Therapeutic treatment
EP1653982A4 (en) Treatment of malodour
EP1575606A4 (en) Treatment of osteoarthritis
GB0210464D0 (en) Therapeutic treatment
IL164951A0 (en) The treatment of pain with lfendropil
GB0101146D0 (en) Treatment of skin conditions
GB0217493D0 (en) Novel methods of treatment
GB0221712D0 (en) Methods of treatment
GB0211297D0 (en) Pain treatment
GB0222505D0 (en) Treatment of pain
GB0325957D0 (en) The treatment of pain
GB0216978D0 (en) The treatment of pain
GB0213870D0 (en) The treatment of pain conditions
GB0322014D0 (en) The treatment of pain
GB0208183D0 (en) Treatment of skin conditions

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)